Qiagen N.V.

General ticker "QGEN" information:

  • Sector: Health Care
  • Industry: Medical - Diagnostics & Research
  • Capitalization: $9.6B (TTM average)

Qiagen N.V. does not follow the US Stock Market performance with the rate: -26.7%.

Estimated limits based on current volatility of 1.7%: low 40.90$, high 42.31$

Factors to consider:

  • Company pays dividends (irregularly): last record date 2026-07-07, amount 0.35$ (Y0.85%)
  • Total employees count: 328 as of 2001
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [43.60$, 60.49$]
  • 2026-12-31 to 2027-12-31 estimated range: [45.65$, 63.36$]

Financial Metrics affecting the QGEN estimates:

  • Negative: with PPE of 19.8 at the end of fiscal year the price was high
  • Positive: Inventory ratio change, % of 0.25 <= 0.80
  • Positive: Industry inventory ratio change (median), % of 0.10 <= 0.28
  • Positive: Operating profit margin, % of 24.90 > 18.40
  • Positive: Return on assets ratio (scaled to [-100,100]) of 6.32 > 6.02
  • Negative: Investing cash flow per share per price, % of -3.07 <= -0.60
  • Negative: 0.01 < Interest expense per share per price, % of 0.33

Similar symbols

Short-term QGEN quotes

Long-term QGEN plot with estimates

Financial data

YTD 2024-12-31 2025-12-31
Operating Revenue $1,978.21MM $2,090.00MM
Operating Expenses $1,880.50MM $1,569.69MM
Operating Income $97.71MM $520.31MM
Non-Operating Income $23.44MM $-30.04MM
Interest Expense $43.84MM $33.26MM
R&D Expense $193.49MM $187.52MM
Income(Loss) $121.15MM $490.26MM
Taxes $37.56MM $65.39MM
Net Income(Loss)* $83.59MM $424.88MM
Stockholders Equity $3,567.34MM $3,778.15MM
Inventory $279.26MM $301.89MM
Assets $5,689.62MM $6,295.96MM
Operating Cash Flow $673.55MM $654.33MM
Capital expenditure $167.17MM $201.05MM
Investing Cash Flow $-249.23MM $-305.28MM
Financing Cash Flow $-422.90MM $-178.98MM
Earnings Per Share** $0.39 $2.04

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.